The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Bacterial Vaginosis Associated with Increased Risk of Female-to-Male HIV-1 Transmission: A Prospective Cohort Analysis among African Couples
Open accessAbstract
BACKGROUND: Bacterial vaginosis (BV), a disruption of the normal vaginal flora, has been associated with a 60% increased risk of HIV-1 acquisition in women and higher concentration of HIV-1 RNA in the genital tract of HIV-1-infected women. However, whether BV, which is present in up to half of African HIV-1-infected women, is associated with an increase in HIV-1 transmission to male partners has not been assessed in previous studies. METHODS AND FINDINGS: We assessed the association between BV on female-to-male HIV-1 transmission risk in a prospective study of 2,236 HIV-1-seropositive women and their HIV-1 uninfected male partners from seven African countries from a randomized placebo-controlled trial that enrolled heterosexual African adults who were seropositive for both HIV-1 and herpes simplex virus (HSV)-2, and their HIV-1-seronegative partners. Participants were followed for up to 24 months; every three months, vaginal swabs were obtained from female partners for Gram stain and male partners were tested for HIV-1. BV and normal vaginal flora were defined as a Nugent score of 7-10 and 0-3, respectively. To reduce misclassification, HIV-1 sequence analysis of viruses from seroconverters and their partners was performed to determine linkage of HIV-1 transmissions. Overall, 50 incident HIV-1 infections occurred in men in which the HIV-1-infected female partner had an evaluable vaginal Gram stain. HIV-1 incidence in men whose HIV-1-infected female partners had BV was 2.91 versus 0.76 per 100 person-years in men whose female partners had normal vaginal flora (hazard ratio 3.62, 95% CI 1.74-7.52). After controlling for sociodemographic factors, sexual behavior, male circumcision, sexually transmitted infections, pregnancy, and plasma HIV-1 RNA levels in female partners, BV was associated with a greater than 3-fold increased risk of female-to-male HIV-1 transmission (adjusted hazard ratio 3.17, 95% CI 1.37-7.33). CONCLUSIONS: This study identified an association between BV and increased risk of HIV-1 transmission to male partners. Several limitations may affect the generalizability of our results including: all participants underwent couples HIV counseling and testing and enrolled in an HIV-1 prevention trial, and index participants had a baseline CD4 count ≥ 250 cells/mm³ and were HSV-2 seropositive. Given the high prevalence of BV and the association of BV with increased risk of both female HIV-1 acquisition and transmission found in our study, if this association proves to be causal, BV could be responsible for a substantial proportion of new HIV-1 infections in Africa. Normalization of vaginal flora in HIV-1-infected women could mitigate female-to-male HIV-1 transmission. TRIAL REGISTRATION: ClinicalTrials.com NCT00194519.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of HIV-1 infection with early antiretroviral therapy.
Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105243 · Cited by 6,873
Nugent, R. P., Krohn, M. A., & Hillier, S. L. (1991) · Journal of Clinical Microbiology · doi:10.1128/jcm.29.2.297-301.1991 · Cited by 3,331
Amsel, R., Totten, P. A., Spiegel, C. A., Chen, K. C. S., Eschenbach, D., & Holmes, K. K. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)91112-9 · Cited by 2,349
Self-citationMolecular Identification of Bacteria Associated with Bacterial Vaginosis
Fredricks, D. N., Fiedler, T. L., & Marrazzo, J. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043802 · Cited by 1,303 · cited 2×
“Bacterial vaginosis (BV) is a common disorder characterized by changes in vaginal flora in which normally predominant Lactobacillus species are replaced by potential pathogens including Gardnerella vaginalis, genital Mycoplasma, and fastidious anaerobic bacteria [6,7].”
BackgroundDonnell, D., Baeten, J. M., Kiarie, J., Thomas, K. K., Stevens, W., Cohen, C. R., McIntyre, J., Lingappa, J. R., & Celum, C. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60705-2 · Cited by 952
Self-citationMartin, H. L., Richardson, B. A., Nyange, P. M., Lavreys, L., Hillier, S. L., Chohan, B., Mandaliya, K., Ndinya‐Achola, J. O., Bwayo, J., & Kreiss, J. (1999) · The Journal of Infectious Diseases · doi:10.1086/315127 · Cited by 891
Bradshaw, C. S., Morton, A. N., Hocking, J., Garland, S. M., Morris, M. B., Moss, L. M., Horvath, L. B., Kuzevska, I., & Fairley, C. K. (2006) · The Journal of Infectious Diseases · doi:10.1086/503780 · Cited by 790
Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial
Wawer, M. J., Sewankambo, N. K., Serwadda, D., Quinn, T. C., Kiwanuka, N., Li, C., Lutalo, T., Nalugoda, F., Gaydos, C. A., Moulton, L. H., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)06439-3 · Cited by 787
Lindsay, R., Nieves, J., Formica, C., Henneman, E., Woelfert, L., Shen, V., Dempster, D., & Cosman, F. (1997) · The Lancet · doi:10.1016/s0140-6736(97)02342-8 · Cited by 749
Bacterial vaginosis and HIV acquisition: A meta-analysis of published studies
Atashili, J., Poole, C., Ndumbe, P. M., Adimora, A. A., & Smith, J. S. (2008) · AIDS · doi:10.1097/qad.0b013e3283021a37 · Cited by 706 · cited 2×
“BV has been associated with a 60% increased risk of HIV-1 acquisition in women [11], and, among women with HIV-1, with higher HIV-1 concentrations in cervicovaginal fluids [12–14].”
BackgroundHIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis
Sewankambo, N., Gray, R. H., Wawer, M. J., Paxton, L., McNairn, D., Wabwire-Mangen, F., Serwadda, D., Li, C., Kiwanuka, N., Hillier, S. L., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)01063-5 · Cited by 655
Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.
Celum, C., Wald, A., Lingappa, J. R., Magaret, A. S., Wang, R. S., Mugo, N., Mujugira, A., Baeten, J. M., Mullins, J. I., Hughes, J. P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0904849 · Cited by 524
Self-citationAdherent Biofilms in Bacterial Vaginosis
Swidsinski, A., Mendling, W., Loening-Baucke, V., Ladhoff, A., Swidsinski, S., Hale, L. P., & Lochs, H. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000183594.45524.d2 · Cited by 481
Swidsinski, A., Mendling, W., Loening-Baucke, V., Swidsinski, S., Dörffel, Y., Scholze, J., Lochs, H., & Verstraelen, H. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.06.039 · Cited by 335
Genital HIV-1 RNA Predicts Risk of Heterosexual HIV-1 Transmission
Baeten, J. M., Kahle, E., Lingappa, J. R., Coombs, R. W., Delany-Moretlwe, S., Nakku-Joloba, E., Mugo, N. R., Wald, A., Corey, L., Donnell, D., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001888 · Cited by 293
Self-citationAnukam, K. C., Osazuwa, E., Osemene, G. I., Ehigiagbe, F., Bruce, A. W., & Reid, G. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2006.08.008 · Cited by 276
Vulvovaginal Symptoms in Women With Bacterial Vaginosis
Klebanoff, M. A., Schwebke, J. R., Zhang, J., Nansel, T. R., Yu, K.-F., & Andrews, W. W. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000134783.98382.b0 · Cited by 267
Clemetson, D. B. A. (1993) · JAMA · doi:10.1001/jama.1993.03500220046024 · Cited by 267
Diagnostic Criteria and Microbial and Epidemiologic Associations
Amsel, R., Totten, P. A., Spiegel, C. A., Chen, K. C. S., & Holmes, K. K. (1983) · Cited by 267
Self-citationThe Effects of Circumcision on the Penis Microbiome
Price, L. B., Liu, C. M., Johnson, K. E., Aziz, M., Lau, M. K., Bowers, J., Ravel, J., Keim, P. S., Serwadda, D., Wawer, M. J., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008422 · Cited by 256
Sha, B. E., Zariffard, M. R., Wang, Q. J., Chen, H. Y., Bremer, J., Cohen, M. H., & Spear, G. T. (2005) · The Journal of Infectious Diseases · doi:10.1086/426394 · Cited by 254
Gray, R. H., Kigozi, G., Serwadda, D., Makumbi, F., Nalugoda, F., Watya, S., Moulton, L., Chen, M. Z., Sewankambo, N. K., Kiwanuka, N., et al. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.07.069 · Cited by 237
The Effect of Treatment of Vaginal Infections on Shedding of Human Immunodeficiency Virus Type 1
Wang, C. C., McClelland, R. S., Reilly, M., Overbaugh, J., Emery, S. R., Mandaliya, K., Chohan, B., Ndinya‐Achola, J., Bwayo, J., & Kreiss, J. K. (2001) · The Journal of Infectious Diseases · doi:10.1086/319287 · Cited by 212
Statistics in Epidemiology: Methods, Techniques, and Applications.
Hertzberg, V. S., Sahai, H., & Khurshid, A. (1997) · Journal of the American Statistical Association · doi:10.2307/2965601 · Cited by 199
The epidemiology of bacterial vaginosis in relation to sexual behaviour
Verstraelen, H., Verhelst, R., Vaneechoutte, M., & Temmerman, M. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-81 · Cited by 189
Bad Bugs, No Drugs: No ESCAPE Revisited
Peterson, L. R. (2009) · Clinical Infectious Diseases · doi:10.1086/605539 · Cited by 187
Statistics in epidemiology: methods, techniques, and applications
Thrusfield, M. (1997) · Preventive Veterinary Medicine · doi:10.1016/s0167-5877(97)00003-2 · Cited by 178
Lingappa, J. R., Baeten, J. M., Wald, A., Hughes, J. P., Thomas, K. K., Mujugira, A., Mugo, N., Bukusi, E. A., Cohen, C. R., Katabira, E. T., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62038-9 · Cited by 152
Self-citationBaeten, J. M., Strick, L. B., Lucchetti, A., Whittington, W. L. H., Sánchez, J., Coombs, R. W., Magaret, A., Wald, A., Corey, L., & Celum, C. (2008) · The Journal of Infectious Diseases · doi:10.1086/593214 · Cited by 138
Self-citationInitiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding
Graham, S. M., Holte, S. E., Peshu, N. M., Richardson, B. A., Panteleeff, D. D., Jaoko, W. G., Ndinya-Achola, J. O., Mandaliya, K. N., Overbaugh, J. M., & McClelland, R. S. (2007) · AIDS · doi:10.1097/qad.0b013e32801424bd · Cited by 136 · cited 1×
“Antiretroviral therapy (ART), through reducing HIV-1 plasma [2] and genital HIV-1 RNA concentrations [3], has been associated with .”
BackgroundHistory and review of bacterial vaginosis
Eschenbach, D. A. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(93)90337-i · Cited by 124
Donoval, B. A., LANDAY, A. L., Moses, S., Agot, K. E., Ndinya-Achola, J. O., Nyagaya, E., MacLean, I., & Bailey, R. C. (2006) · American Journal of Clinical Pathology · doi:10.1309/jvhqvdjdykm58eph · Cited by 124
Cohen, C. R., Plummer, F. A., Mugo, N., Maclean, I., Shen, C., Bukusi, E. A., Irungu, E., Sinei, S. K., Bwayo, J. J., & Brunham, R. C. (1999) · AIDS · doi:10.1097/00002030-199902250-00004 · Cited by 113
Self-citationHemmerling, A., Harrison, W., Schroeder, A., Park, J., Korn, A. P., Shiboski, S. C., Foster-Rosales, A. F., & Cohen, C. R. (2010) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181e50026 · Cited by 113
Self-citationInfectious correlates of HIV-1 shedding in the female upper and lower genital tracts
Coleman, J. S., Hitti, J. E., Bukusi, E. A., Mwachari, C., Muliro, A., Nguti, R., Gausman, R., Jensen, S., Patton, D. L., Lockhart, D., et al. (2007) · AIDS · doi:10.1097/qad.0b013e328012b838 · Cited by 101
Self-citationMcClelland, R. S., Richardson, B. A., Hassan, W., Chohan, V., Lavreys, L., Mandaliya, K. N., Kiarie, J. N., Jaoko, W. G., Ndinya‐Achola, J. O., Baeten, J. M., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/587490 · Cited by 96
Self-citationViral Linkage in HIV-1 Seroconverters and Their Partners in an HIV-1 Prevention Clinical Trial
Campbell, M. S., Mullins, J. I., Hughes, J. P., Celum, C., Wong, K. G., Raugi, D. N., Sorensen, S., Stoddard, J. N., Zhao, H. C., Deng, W., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016986 · Cited by 89
Self-citationForsum, U., Jakobsson, T., Larsson, P.-G., SCHMIDT, H., Beverly, A., Bjørnerem, Å., Carlsson, B., CSANGO, P. A., Donders, G. G. G., Hay, P., et al. (2002) · Apmis · doi:10.1034/j.1600-0463.2002.1101107.x · Cited by 84
Bacterial Vaginosis: Risk Factors Among Kenyan Women and Their Male Partners
Bukusi, E. A., Cohen, C. R., Meier, A. S., Waiyaki, P. G., Nguti, R., Njeri, J. N., & Holmes, K. K. (2006) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000200551.07573.df · Cited by 75
Self-citationProbiotic strategies for the treatment and prevention of bacterial vaginosis
MacPhee, R. A., Hummelen, R., Bisanz, J. E., Miller, W. L., & Reid, G. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.512004 · Cited by 74
Hashemi, F. B., Ghassemi, M., Faro, S., Aroutcheva, A. A., & Spear, G. T. (2000) · The Journal of Infectious Diseases · doi:10.1086/315455 · Cited by 72
Lower Genital Tract Infections Among HIV-Infected and High-Risk Uninfected Women
Greenblatt, R. M., Bacchetti, P., Barkan, S. E., Augenbraun, M. H., Silver, S., Delapenha, R., Garcia, P. J., Mathur, U., Miotti, P., & Burns, D. (1999) · Sexually Transmitted Diseases · doi:10.1097/00007435-199903000-00004 · Cited by 70
Probiotics: potential to prevent HIV and sexually transmitted infections in women
Bolton, M., van der Straten, A., & Cohen, C. R. (2008) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31815b017a · Cited by 67 · cited 1×
“While a large community randomized controlled trial that provided presumptive treatment of STIs including metronidazole for BV failed to reduce HIV-1 incidence [49], ongoing studies are evaluating more frequent presumptive BV therapy [42], while others are studying naturally occurring and genetically enhanced probioti…”
BackgroundSelf-citationCorrelates of HIV-1 Genital Shedding in Tanzanian Women
Tanton, C., Weiss, H. A., LeGoff, J., Changalucha, J. M., Rusizoka, M., Baisley, K. J., Everett, D., Ross, D. A., Bélec, L., Hayes, R., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017480 · Cited by 64
Rebbapragada, A., Howe, K. L., Wachihi, C., Pettengell, C., Sunderji, S., Huibner, S., Ball, T. B., Plummer, F. A., Jaoko, W. G., & Kaul, R. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318189a7ca · Cited by 60
Human immunodeficiency virus‐1 acquisition in genital mucosa: Langerhans cells as key‐players
de Jong, M. A. W. P., & Geijtenbeek, T. B. H. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.02046.x · Cited by 58
Prevalence of Gardnerella vaginalis and Atopobium vaginae in Virginal Women
Tabrizi, S. N., Fairley, C. K., Bradshaw, C. S., & Garland, S. M. (2006) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000216161.42272.be · Cited by 30
Thoma, M. E., Gray, R. H., Kiwanuka, N., Aluma, S., Wang, M., Sewankambo, N. K., & Wawer, M. J. (2010) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181f0bdd0 · Cited by 29
Detection of Fastidious Vaginal Bacteria in Women with HIV Infection and Bacterial Vaginosis
Mitchell, C. M., Moreira, C., Fredricks, D. N., Paul, K. J., Caliendo, A. M., Kurpewski, J., Ingersoll, J., & Cu‐Uvin, S. (2009) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1155/2009/236919 · Cited by 27
Bukusi, E. A., Thomas, K. K., Nguti, R., Cohen, C. R., Weiss, N. S., Coombs, R. W., & Holmes, K. K. (2011) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318214b82d · Cited by 23
Self-citationMoreira, C., Venkatesh, K. K., DeLong, A. K., Liu, T., Kurpewski, J., Ingersoll, J., Caliendo, A. M., & Cu‐Uvin, S. (2009) · Clinical Infectious Diseases · doi:10.1086/605540 · Cited by 12
Probiotics: The Potential for a Live Microbicide to Prevent HIV
Hemmerling, A., & Cohen, C. R. (2011) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3182056ad9 · Cited by 4
Self-citation
Research works printed but not linked: 2
- RE Chaisson, 2000, Association of initial CD4 cell count and viral load with response to highly active antiretroviral therapy., JAMA, 284, 3128, 10.1001/jama.284.24.3123 · doi:10.1001/jama.284.24.3123
- JA Simoes, 2001, Human immunodeficiency virus type 1 stimulatory activity by Gardnerella vaginalis: relationship to biotypes and other pathogenic characteristics., J Infect Dis, 184, 22, 10.1086/321002 · DOI
Cited by
Sexually Transmitted Diseases Treatment Guidelines, 2010
(2011) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2011.04.006 · Cited by 2,076
Romero, R., Hassan, S. S., Gajer, P., Tarca, A. L., Fadrosh, D. W., Nikita, L., Galuppi, M., Lamont, R. F., Chaemsaithong, P., Miranda, J., et al. (2014) · Microbiome · doi:10.1186/2049-2618-2-4 · Cited by 852
Sexually transmitted infections: challenges ahead
Unemo, M., Bradshaw, C. S., Hocking, J. S., de Vries, H. J. C., Francis, S. C., Mabey, D., Marrazzo, J. M., Sonder, G. J. B., Schwebke, J. R., Hoornenborg, E., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30310-9 · Cited by 751
Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health
Petrova, M. I., Lievens, E., Malik, S., Imholz, N., & Lebeer, S. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00081 · Cited by 523
“In addition, BV has been also associated with increased rates of transmission of HIV from infected women to their male partners, which suggests that BV could be responsible for new HIV-1 infections in Africa (Cohen et al., 2012).”
BackgroundInfluentialThe global epidemiology of bacterial vaginosis: a systematic review
Kenyon, C., Colebunders, R., & Crucitti, T. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.05.006 · Cited by 464
Metadata
- Authors
- Cohen, C. R., Lingappa, J. R., Baeten, J. M., Ngayo, M. O., Spiegel, C. A., Hong, T., Donnell, D., Celum, C., Kapiga, S., Delany, S., & Bukusi, E. A.
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-06-26
- Volume
- 9
- Issue
- 6
- Pages
- e1001251
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2027378590
- Cited by
- 374
- References
- 52
- FWCI
- 24.86
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.